Skip to content

Clinical trials

Phase 1/2 Hypertension, Pulmonary trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypertension, Pulmonary Phase: Phase 1/2 Country / region: United States Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20112
20122
20191
20241
20251
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated3
Completed2
Not yet recruiting2
Recruiting2
Withdrawn2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
35Pharma Inc1
AdventHealth1
Ann & Robert H Lurie Children's Hospital of Chicago1
Chan, Stephen, MD, PhD1
Duke University1
National Heart, Lung, and Blood Institute (NHLBI)1
University of Illinois at Chicago1
University of Oklahoma1
University of Pennsylvania1
Virginia Commonwealth University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypertension, Pulmonary11
Anemia, Sickle Cell1
Bronchopulmonary Dysplasia1
Cardiovascular Diseases1
Heart Defects, Congenital1
Heart Diseases1
Heart Failure1
Lung Diseases1
Lung Diseases, Interstitial1
Obesity1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.